...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: something. anything.
3
Feb 28, 2020 02:21PM
5
Feb 28, 2020 02:37PM

Thier website indicates that they will be attending ASCO, the premier annual Oncology conference.  I was hoping to see them presenting something here, which is still a possibility at this time, I guess.

 

Does anyone recall if fthey have attended ASCO in the recent past?

1
Mar 03, 2020 08:19PM
1
Mar 04, 2020 07:47AM
Share
New Message
Please login to post a reply